NCT05070299

Brief Summary

This is a single arm study to evaluate the feasibility, adherence, and usefulness of a psychosexual education partner program (PEPP) to improve partner communication and sexual function. This study is intended to get initial input from a small group of up to 10 women and their partners about the appropriateness, usefulness, and critical nature of the content as well as the feasibility and appeal of the method of delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 7, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2022

Completed
Last Updated

February 13, 2023

Status Verified

February 1, 2023

Enrollment Period

6 months

First QC Date

September 21, 2021

Last Update Submit

February 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Attrition rate (feasibility)

    After completion of each module the interventionist will contact patients and their partners by phone and document completion of the module's exercise. Anyone who does not provide data both before and after completing the surveys for the study will be considered to be prematurely withdrawn and included in the attrition count. The intervention will be considered feasible if the attrition rate is 25% or less at week 6 (+2 weeks). Withdrawal reasons will be captured and reported by category.

    Week 6 (+2 weeks)

Secondary Outcomes (5)

  • Home practice rate (acceptability)

    Week 6 (+2 weeks)

  • Participant experience assessed using Thematic Analysis

    Week 6 (+2 weeks)

  • Impact of intervention, measured by Dyadic Sexual Communication (DSC)

    Baseline to week 6 (+2 weeks)

  • Impact of intervention, measured by PROMIS® Sexual Function and Satisfaction V2.0 (PROMIS SexF V2)

    Baseline to week 6 (+2 weeks)

  • Impact of intervention, measured by Revised Dyadic Adjustment Scale (RDAS)

    Baseline to week 6 (+2 weeks)

Study Arms (1)

Psychosexual Educational Partners Program (PEPP)

EXPERIMENTAL

Women and their partners will work through a three module workbook together, completing each module over a 2-week period (6 weeks total).

Behavioral: Psychosexual Educational Partner Program (PEPP)

Interventions

A communication and intimacy promotion kit consisting of three modules devoted to information sharing, partner communication and activities for building intimacy.

Psychosexual Educational Partners Program (PEPP)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 female with a history of any stage breast and/or gynecological cancer.
  • Completed primary treatment (chemotherapy, radiation and/or surgery) ≥ 3 months and ≤ 5 years prior to registration.
  • May use concurrent adjuvant endocrine therapy or HER2-targeted therapy while on study.
  • Responds yes to the question "Has there been change in communication and/or intimacy with your partner since your cancer diagnosis?"
  • Ability to read and write English.
  • A stable partner, defined as anyone with whom the woman has had an intimate relationship with for at least 3 months prior to her cancer diagnosis.
  • Both partner and woman must agree to participate in the study and sign informed consent to the study.

You may not qualify if:

  • Antidepressants are allowed if a person has been on them for 30 days prior to registration, and dose or treatment is not expected to change.
  • Past history of sexual abuse.
  • Psychiatric disorder such as major depressive disorder, bipolar disorder, obsessive compulsive disorder or schizophrenia. (Defined per medical history and/or patient self-report.)
  • Currently enrolled in another study that addresses sexual health (enrollment in other clinical trials will be allowed).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, 48109, United States

Location

Related Publications (1)

  • Arring NM, Reese JB, Lafferty C, Barton DL, Carter J. A Sexual Health Self-Management Intervention (Psychosexual Educational Partners Program) for Couples With a History of Breast and Gynecological Cancer: Mixed Methods Feasibility Study. JMIR Form Res. 2025 Oct 21;9:e75743. doi: 10.2196/75743.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Noel Arring, DNP, PhD, RN, OCN

    University of Michigan Rogel Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2021

First Posted

October 7, 2021

Study Start

March 15, 2022

Primary Completion

August 29, 2022

Study Completion

August 29, 2022

Last Updated

February 13, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations